Key result
Esc2 enhances Smc5/6 SUMOylation activity by binding Ubc9 and Nse2 to promote efficient SUMO transfer.
Why the study?
With a limited set of SUMO E3 ligases identified, how substrate specificity is achieved and the molecular mechanism by which Esc2 stimulates Nse2-dependent SUMOylation remained open questions.
Esc2 enhances the SUMO E3 ligase activity of the Smc5/6 complex by directly interacting with the Nse2 SIM2 motif, facilitating DNA repair and genome integrity.
Defines novel E2 cofactor mechanism for substrate-specific SUMOylation in yeast; leaves open conservation in human genome maintenance pathways.
Post-translational modification by SUMO regulates a wide array of cellular processes. Despite the large number of SUMOylated substrates, only a limited set of SUMO E3 ligases have been identified, raising important questions about how substrate specificity is achieved. In budding yeast, the nuclear protein Esc2 functions as a cofactor in the SUMO pathway through its interaction with the E2 enzyme Ubc9. Esc2 is relevant under conditions of replicative stress, promoting the removal of recombination intermediates during DNA replication. This role has been largely attributed to its ability to enhance the SUMO E3 ligase activity of Nse2, a subunit of the Smc5/6 complex. Here, we uncover the molecular mechanism underlying Esc2-mediated stimulation of Nse2-dependent SUMOylation by identifying a direct interaction between the C-terminal SUMO-interacting motif of Nse2 and the Esc2 SLD2 domain. These coordinated interactions facilitate the formation of a productive E3-E2~SUMO complex and promote efficient SUMO transfer to substrates such as Sgs1 and Top3, thereby enhancing the processing of recombination intermediates and contributing to genome integrity. Esc2 promotes Nse2-dependent SUMOylation by directly binding Nse2 through its SLD2 domain. This interaction stabilizes a productive E3–E2~SUMO complex, enhances SUMO transfer to substrates such as Sgs1 and Top3, and preserves genome integrity.
No takes yet. Share an insight, caveat, or question.
Borràs-Gas et al. (2026) studied this question. Esc2 vs. Absence of Esc2 or mutant variants was evaluated on E2~SUMO thioester discharge and substrate SUMOylation. Esc2 enhances the SUMOylation activity of the Smc5/6 complex by simultaneously binding to the backside of Ubc9 and the SIM2 motif of Nse2, promoting efficient SUMO transfer to substrates.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: